430 related articles for article (PubMed ID: 24446210)
1. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
[TBL] [Abstract][Full Text] [Related]
2. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development.
Rubio R; Gutierrez-Aranda I; Sáez-Castillo AI; Labarga A; Rosu-Myles M; Gonzalez-Garcia S; Toribio ML; Menendez P; Rodriguez R
Oncogene; 2013 Oct; 32(41):4970-80. PubMed ID: 23222711
[TBL] [Abstract][Full Text] [Related]
3. Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells.
Wang JY; Wu PK; Chen PC; Lee CW; Chen WM; Hung SC
Stem Cells Transl Med; 2017 Feb; 6(2):512-526. PubMed ID: 28191765
[TBL] [Abstract][Full Text] [Related]
4. Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo.
Rubio R; García-Castro J; Gutiérrez-Aranda I; Paramio J; Santos M; Catalina P; Leone PE; Menendez P; Rodríguez R
Cancer Res; 2010 May; 70(10):4185-94. PubMed ID: 20442289
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein Smads signaling in mesenchymal stem cells affected by osteoinductive calcium phosphate ceramics.
Tang Z; Wang Z; Qing F; Ni Y; Fan Y; Tan Y; Zhang X
J Biomed Mater Res A; 2015 Mar; 103(3):1001-10. PubMed ID: 24889783
[TBL] [Abstract][Full Text] [Related]
6. cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic Osteosarcoma.
He Y; Zhu W; Shin MH; Gary J; Liu C; Dubois W; Hoover SB; Jiang S; Marrogi E; Mock B; Simpson RM; Huang J
Stem Cell Reports; 2017 Jun; 8(6):1630-1644. PubMed ID: 28552607
[TBL] [Abstract][Full Text] [Related]
7. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells.
Hanada K; Dennis JE; Caplan AI
J Bone Miner Res; 1997 Oct; 12(10):1606-14. PubMed ID: 9333121
[TBL] [Abstract][Full Text] [Related]
8. Bone formation and degradation of a highly porous biphasic calcium phosphate ceramic in presence of BMP-7, VEGF and mesenchymal stem cells in an ectopic mouse model.
Roldán JC; Detsch R; Schaefer S; Chang E; Kelantan M; Waiss W; Reichert TE; Gurtner GC; Deisinger U
J Craniomaxillofac Surg; 2010 Sep; 38(6):423-30. PubMed ID: 20189819
[TBL] [Abstract][Full Text] [Related]
9. Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics.
Kasten P; Vogel J; Luginbühl R; Niemeyer P; Weiss S; Schneider S; Kramer M; Leo A; Richter W
Cells Tissues Organs; 2006; 183(2):68-79. PubMed ID: 17053323
[TBL] [Abstract][Full Text] [Related]
10. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis.
Shimizu T; Ishikawa T; Sugihara E; Kuninaka S; Miyamoto T; Mabuchi Y; Matsuzaki Y; Tsunoda T; Miya F; Morioka H; Nakayama R; Kobayashi E; Toyama Y; Kawai A; Ichikawa H; Hasegawa T; Okada S; Ito T; Ikeda Y; Suda T; Saya H
Oncogene; 2010 Oct; 29(42):5687-99. PubMed ID: 20676132
[TBL] [Abstract][Full Text] [Related]
11. Bone forming capacity of cell- and growth factor-based constructs at different ectopic implantation sites.
Ma J; Yang F; Both SK; Prins HJ; Helder MN; Pan J; Cui FZ; Jansen JA; van den Beucken JJ
J Biomed Mater Res A; 2015 Feb; 103(2):439-50. PubMed ID: 24737694
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model.
Tsukamoto S; Honoki K; Fujii H; Tohma Y; Kido A; Mori T; Tsujiuchi T; Tanaka Y
Int J Oncol; 2012 Jan; 40(1):163-9. PubMed ID: 21971610
[TBL] [Abstract][Full Text] [Related]
13. Rat bone marrow mesenchymal stem cells undergo malignant transformation via indirect co-cultured with tumour cells.
Liu J; Zhang Y; Bai L; Cui X; Zhu J
Cell Biochem Funct; 2012 Dec; 30(8):650-6. PubMed ID: 22763674
[TBL] [Abstract][Full Text] [Related]
14. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
Wang L; Park P; La Marca F; Than KD; Lin CY
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
[TBL] [Abstract][Full Text] [Related]
15. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells.
Raval P; Hsu HH; Schneider DJ; Sarras MP; Masuhara K; Bonewald LF; Anderson HC
J Dent Res; 1996 Jul; 75(7):1518-23. PubMed ID: 8876605
[TBL] [Abstract][Full Text] [Related]
16. Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier.
Kasten P; Vogel J; Luginbühl R; Niemeyer P; Tonak M; Lorenz H; Helbig L; Weiss S; Fellenberg J; Leo A; Simank HG; Richter W
Biomaterials; 2005 Oct; 26(29):5879-89. PubMed ID: 15913762
[TBL] [Abstract][Full Text] [Related]
17. Recombinant growth/differentiation factor-5 (GDF-5) stimulates osteogenic differentiation of marrow mesenchymal stem cells in porous hydroxyapatite ceramic.
Shimaoka H; Dohi Y; Ohgushi H; Ikeuchi M; Okamoto M; Kudo A; Kirita T; Yonemasu K
J Biomed Mater Res A; 2004 Jan; 68(1):168-76. PubMed ID: 14661262
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein-2 in biodegradable gelatin and β-tricalcium phosphate sponges enhances the in vivo bone-forming capability of bone marrow mesenchymal stem cells.
Tadokoro M; Matsushima A; Kotobuki N; Hirose M; Kimura Y; Tabata Y; Hattori K; Ohgushi H
J Tissue Eng Regen Med; 2012 Apr; 6(4):253-60. PubMed ID: 21548136
[TBL] [Abstract][Full Text] [Related]
19. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
20. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.
Walia MK; Ho PM; Taylor S; Ng AJ; Gupte A; Chalk AM; Zannettino AC; Martin TJ; Walkley CR
Elife; 2016 Apr; 5():. PubMed ID: 27070462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
